PlainRecalls
FDA Drug Moderate Class II Ongoing

Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.

Reported: December 31, 2025 Initiated: December 12, 2025 #D-0242-2026

Product Description

Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.

Reason for Recall

Presence of particulate matter: potential presence of metal particulates in the product.

Details

Recalling Firm
Merck Sharp & Dohme LLC
Units Affected
845 kits
Distribution
Nationwide in the USA
Location
Wilson, NC

Frequently Asked Questions

What product was recalled?
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.. Recalled by Merck Sharp & Dohme LLC. Units affected: 845 kits.
Why was this product recalled?
Presence of particulate matter: potential presence of metal particulates in the product.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 31, 2025. Severity: Moderate. Recall number: D-0242-2026.